Shuttle Pharmaceuticals Holdings, Inc. — Form 8-K
Filed August 28, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 94/100
What the filing says
Shuttle Pharmaceuticals (NASDAQ: SHPH, ~$4.7M market cap) failed to file its Q2 2026 Form 10-Q by the required due date and received a NASDAQ noncompliance notice on August 28, 2026. The company must submit a compliance plan by October 27, 2026; if accepted, NASDAQ may grant a grace period until February 22, 2027 to regain compliance. Failure to regain compliance within that window triggers automatic delisting from NASDAQ.
Why this rating
Delisting threat is existential for a $4.7M microcap. Failure to meet SEC periodic filing deadlines signals severe operational/financial distress. Loss of NASDAQ listing would eliminate market access and institutional credibility.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.